a crop up image of woman scratching her dry skin (Tralokinumab)

Article

PDF: Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults

Name: PDF: Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults
Price: 1.99 USD
Availability: InStock

$1.99

PDF Download: Tralokinumab is an effective and safe treatment for adult patients with moderate-to-severe AD. It may be used alone or in combination with TCS. This biologic can be considered first-line treatment after failure of or intolerance to topical therapies.

Read online:
Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults

Category: Dermatology

PDF: Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults

Related products

PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses

PDF: Update on Drugs & Devices: September – October 2019

PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma

PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea